JPMorgan Chase & Co’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-75
| Closed | -$125 | – | 6413 |
|
|
2024
Q4 | $125 | Sell |
75
-238
| -76% | -$397 | ﹤0.01% | 5926 |
|
|
2024
Q3 | $736 | Sell |
313
-227
| -42% | -$534 | ﹤0.01% | 5688 |
|
|
2024
Q2 | $1.57K | Sell |
540
-80
| -13% | -$233 | ﹤0.01% | 5533 |
|
|
2024
Q1 | $1.89K | Sell |
620
-6,215
| -91% | -$18.9K | ﹤0.01% | 5570 |
|
|
2023
Q4 | $19.4K | Buy |
6,835
+4,647
| +212% | +$13.2K | ﹤0.01% | 5249 |
|
|
2023
Q3 | $5.91K | Buy |
2,188
+1,601
| +273% | +$4.32K | ﹤0.01% | 5405 |
|
|
2023
Q2 | $939 | Buy |
+587
| New | +$939 | ﹤0.01% | 5556 |
|
|
2021
Q2 | – | Sell |
-2,769
| Closed | -$421K | – | 5473 |
|
|
2021
Q1 | $421K | Buy |
2,769
+2,392
| +634% | +$364K | ﹤0.01% | 4133 |
|
|
2020
Q4 | $45K | Buy |
377
+202
| +115% | +$24.1K | ﹤0.01% | 4467 |
|
|
2020
Q3 | $42K | Buy |
175
+70
| +67% | +$16.8K | ﹤0.01% | 4333 |
|
|
2020
Q2 | $30K | Buy |
+105
| New | +$30K | ﹤0.01% | 4346 |
|
|
2019
Q3 | – | Sell |
-62
| Closed | -$22K | – | 4760 |
|
|
2019
Q2 | $22K | Buy |
+62
| New | +$22K | ﹤0.01% | 4491 |
|